Beyond Euthyroid Sick Syndrome: Pre-Admission Levothyroxine Use and Thyroid Hormone–Outcome Associations in Hospitalized Patients
- 1Institute of Endocrinology, Bnai Zion Medical Center, 47 Eliyahu Golomb Avenue, Haifa 3339419, Israel
- 2The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, 1 Efron Street, Haifa 3339101, Israel
- 3Clinical Laboratories Division, Bnai Zion Medical Center, Haifa 3339419, Israel
Abstract
Background/Objectives: Pre-admission levothyroxine use may influence the interpretation of thyroid tests beyond the conventional framework of non-thyroidal illness syndrome (NTIS). We examined whether thyroid hormone–outcome associations differed by treatment status. Methods: This retrospective study included medical inpatients with thyroid-stimulating hormone (TSH) < 5 mIU/L during 2006–2024. Propensity-score matching used age, sex, and 16 comorbidity indicators. Complete-case negative-binomial and logistic models examined hospitalization length and in-hospital mortality, with treatment-by-hormone interactions. Results: Among 14,332 matched patients, 3717 had complete data (1986 users; 1731 nonusers). Higher free triiodothyronine (FT3) in nonusers was associated with shorter hospitalization (incidence–rate ratio [IRR] 0.76, 95% confidence interval [CI] 0.73–0.80) and lower mortality odds (odds ratio [OR] 0.47, 95% CI 0.35–0.62). Free thyroxine (FT4) associations differed by levothyroxine use for both hospitalization length (interaction IRR 0.95, 95% CI 0.94–0.97) and mortality (interaction OR 0.83, 95% CI 0.77–0.90; both p < 0.001). At mean hormone concentrations, levothyroxine use was associated with shorter hospitalization (IRR 0.87, 95% CI 0.81–0.94) and lower mortality odds (OR 0.53, 95% CI 0.35–0.82). Crude mortality was 4.6% versus 5.0%, respectively; the conditional estimates represent a different comparison. Conclusions: FT4–outcome associations differed by pre-admission levothyroxine use, extending the established low-T3 prognostic framework to treatment-specific hormone patterns. These findings support considering treatment history when interpreting inpatient thyroid tests. Selective testing and residual confounding limit causal interpretation.
Related
- Does Source of Admission Matter? Hospital Outcomes of Older Adults Requiring Nursing Care Hospitalized in Internal Medicine Departments
- Clinical features of COVID-19 patients hospitalized at the Tashkent State Medical University and risk factors for intensive care unit admission: a cross-sectional study from Uzbekistan, Central Asia
- Association Between Initial Admission Ward and In-Hospital Mortality Among Patients Hospitalized for Cardiovascular Emergencies ― A Nationwide Study Using the JROAD-DPC Database ―
- Blood eosinophil count and intensive care unit admission in patients hospitalized for acute exacerbation of COPD: a retrospective cohort study.
- Nutritional Status at Admission and Clinical Outcomes in Hospitalized Patients with COVID-19: Results from the MODIeCOSe in Italy Study
BibTeX
@article{sheikhahmad2026beyond,
title = {{Beyond Euthyroid Sick Syndrome: Pre-Admission Levothyroxine Use and Thyroid Hormone–Outcome Associations in Hospitalized Patients}},
author = {Mohammad Sheikh-Ahmad and Ilana Rosenblatt and Hadas Rabani and Clara Henig and Balsam Dakwar and Ekaterina Yovanovich and Emad Khoury and Leonard Saiegh},
journal = {Journal of Clinical Medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15218382},
url = {https://www.mdpi.com/2077-0383/15/21/8382},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Beyond Euthyroid Sick Syndrome: Pre-Admission Levothyroxine Use and Thyroid Hormone–Outcome Associations in Hospitalized Patients
AU - Mohammad Sheikh-Ahmad
AU - Ilana Rosenblatt
AU - Hadas Rabani
AU - Clara Henig
AU - Balsam Dakwar
AU - Ekaterina Yovanovich
AU - Emad Khoury
AU - Leonard Saiegh
PY - 2026
DA - 2026/10/28
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15218382
UR - https://www.mdpi.com/2077-0383/15/21/8382
AB - Background/Objectives: Pre-admission levothyroxine use may influence the interpretation of thyroid tests beyond the conventional framework of non-thyroidal illness syndrome (NTIS). We examined whether thyroid hormone–outcome associations differed by treatment status. Methods: This retrospective study included medical inpatients with thyroid-stimulating hormone (TSH) < 5 mIU/L during 2006–2024. Propensity-score matching used age, sex, and 16 comorbidity indicators. Complete-case negative-binomial and logistic models examined hospitalization length and in-hospital mortality, with treatment-by-hormone interactions. Results: Among 14,332 matched patients, 3717 had complete data (1986 users; 1731 nonusers). Higher free triiodothyronine (FT3) in nonusers was associated with shorter hospitalization (incidence–rate ratio [IRR] 0.76, 95% confidence interval [CI] 0.73–0.80) and lower mortality odds (odds ratio [OR] 0.47, 95% CI 0.35–0.62). Free thyroxine (FT4) associations differed by levothyroxine use for both hospitalization length (interaction IRR 0.95, 95% CI 0.94–0.97) and mortality (interaction OR 0.83, 95% CI 0.77–0.90; both p < 0.001). At mean hormone concentrations, levothyroxine use was associated with shorter hospitalization (IRR 0.87, 95% CI 0.81–0.94) and lower mortality odds (OR 0.53, 95% CI 0.35–0.82). Crude mortality was 4.6% versus 5.0%, respectively; the conditional estimates represent a different comparison. Conclusions: FT4–outcome associations differed by pre-admission levothyroxine use, extending the established low-T3 prognostic framework to treatment-specific hormone patterns. These findings support considering treatment history when interpreting inpatient thyroid tests. Selective testing and residual confounding limit causal interpretation.
SN - 2077-0383
ER -